Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin sodium and clavulanate potassium (7:1) for acute uncomplicated pyelonephritis
CTR20222770Phase 2Terminated
- Sponsor
- Xiangbei Wellman Pharmaceutical
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amoxicillin + clavulanate in pyelonephritis, sponsored by Xiangbei Wellman Pharmaceutical. Started Dec 2022; status: terminated.
02
Drugs
amoxicillin + clavulanate
03
Conditions
pyelonephritis
Beyond the preview
Go deeper on CTR20222770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222770.